122 related articles for article (PubMed ID: 23148625)
1. Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival.
Chaker S; Kak I; MacMillan C; Ralhan R; Walfish PG
Thyroid; 2013 Feb; 23(2):201-8. PubMed ID: 23148625
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.
Burkhardt M; Mayordomo E; Winzer KJ; Fritzsche F; Gansukh T; Pahl S; Weichert W; Denkert C; Guski H; Dietel M; Kristiansen G
J Clin Pathol; 2006 Apr; 59(4):403-9. PubMed ID: 16484444
[TBL] [Abstract][Full Text] [Related]
3. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.
Weichert W; Knösel T; Bellach J; Dietel M; Kristiansen G
J Clin Pathol; 2004 Nov; 57(11):1160-4. PubMed ID: 15509676
[TBL] [Abstract][Full Text] [Related]
4. Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas.
Chaker S; Kashat L; Voisin S; Kaur J; Kak I; MacMillan C; Ozcelik H; Siu KW; Ralhan R; Walfish PG
Proteomics; 2013 Mar; 13(5):771-87. PubMed ID: 23319340
[TBL] [Abstract][Full Text] [Related]
5. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
[TBL] [Abstract][Full Text] [Related]
6. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
[TBL] [Abstract][Full Text] [Related]
7. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.
Wachowiak R; Mayer S; Kaifi J; Gebauer F; Izbicki JR; Lacher M; Bockhorn M; Tachezy M
Anticancer Res; 2016 Aug; 36(8):3991-5. PubMed ID: 27466504
[TBL] [Abstract][Full Text] [Related]
11. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.
Tachezy M; Effenberger K; Zander H; Minner S; Gebauer F; Vashist YK; Sauter G; Pantel K; Izbicki JR; Bockhorn M
Int J Cancer; 2012 Jul; 131(2):396-405. PubMed ID: 21858815
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of activated leukocyte cell adhesion molecule in prostatic intraepithelial neoplasia and adenocarcinoma].
Zheng X; Ding W; Xie L; Chen Z
Zhonghua Nan Ke Xue; 2004 Apr; 10(4):265-8. PubMed ID: 15148921
[TBL] [Abstract][Full Text] [Related]
13. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
14. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
Clauditz TS; von Rheinbaben K; Lebok P; Minner S; Tachezy M; Borgmann K; Knecht R; Sauter G; Wilczak W; Blessmann M; Münscher A
Pathol Res Pract; 2014 Oct; 210(10):649-55. PubMed ID: 25028217
[TBL] [Abstract][Full Text] [Related]
15. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.
King JA; Ofori-Acquah SF; Stevens T; Al-Mehdi AB; Fodstad O; Jiang WG
Breast Cancer Res; 2004; 6(5):R478-87. PubMed ID: 15318930
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis.
Davies SR; Dent C; Watkins G; King JA; Mokbel K; Jiang WG
Oncol Rep; 2008 Feb; 19(2):555-61. PubMed ID: 18202807
[TBL] [Abstract][Full Text] [Related]
17. Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.
Miccichè F; Da Riva L; Fabbi M; Pilotti S; Mondellini P; Ferrini S; Canevari S; Pierotti MA; Bongarzone I
PLoS One; 2011 Feb; 6(2):e17141. PubMed ID: 21364949
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.
Piao D; Jiang T; Liu G; Wang B; Xu J; Zhu A
Mol Biol Rep; 2012 Jan; 39(1):661-8. PubMed ID: 21670959
[TBL] [Abstract][Full Text] [Related]
20. Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma.
van den Brand M; Takes RP; Blokpoel-deRuyter M; Slootweg PJ; van Kempen LC
Oral Oncol; 2010 May; 46(5):393-8. PubMed ID: 20371201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
